NDC 43742-2085 – HA2CG Evolution

7-oxodehydroepiandrosterone 3-acetate 30 [hp_X]/mL; Apc-356433 8 [hp_X]/mL; Apc-356434 8 [hp_X]/mL; Adenosine Triphosphate Disodium 30 [hp_X]/mL; Vincetoxicum… · Liquid · Oral

Human Otc Drug

Product NDC43742-2085

Product details

Brand name
HA2CG Evolution
Generic name
7-Oxo-Dehydroepiandrosterone 3-Acetate, AACG-A, AACG-B, Adenosinum Triphosphoricum Dinatrum, Asclepias Vincetoxicum, Calcarea Carbonica, Cerebrum Suis, Echinacea (Angustifolia), Gambogia, Gelsemium Sempervirens, Graphites, Hepar Suis, Hypothalamus (Suis), Insulinum (Suis), Kidney (Suis), Methylcobalamin, Nux Vomica, Pancreas Suis, Phytolacca Decandra, Proteus (Vulgaris), Sarcolacticum Acidum, Stomach (Suis)
Labeler
Deseret Biologicals, Inc.
Dosage form
Liquid
Route
Oral
Marketing category
UNAPPROVED HOMEOPATHIC
Marketed since
May 31, 2023
Listing expires
December 31, 2026
Pharmacologic class
Non-Standardized Plant Allergenic Extract

Active ingredients

Uses, dosage, side effects and warnings for HA2CG Evolution →

Package NDC codes (1)

Package NDCDescriptionSince
43742-2085-130 mL in 1 BOTTLE, DROPPER (43742-2085-1)May 31, 2023

Other HA2CG Evolution products